Printing composite nanofilaments for use in a simple and low-cost 3D pen

In Situ Printing of Polylactic Acid/Nanoceramic Filaments for the Repair of Bone Defects Using a Portable 3D Device

In situ 3D printing is attractive for the direct repair of bone defects in underdeveloped countries and in emergency situations. So far, the lack of an interesting method to produce filament using FDA-approved biopolymers and nanoceramics combined with a portable strategy limits the use of in situ 3D printing. Herein, we investigated the osseointegration of new nanocomposite filaments based on polylactic acid (PLA), laponite (Lap), and hydroxyapatite (Hap) printed directly at the site of the bone defect in rats using a portable 3D printer. The filaments were produced using a single-screw extruder (L/D = 26), without the addition of solvents that can promote the toxicity of the materials. In vitro performance was evaluated in the cell differentiation process with mesenchymal stem cells (MSC) by an alkaline phosphatase activity test and visualization of mineralization nodules; a cell viability test and total protein dosage were performed to evaluate cytotoxicity. For the in vivo analysis, the PLA/Lap composite filaments with a diameter of 1.75 mm were printed directly into bone defects of Wistar rats using a commercially available portable 3D printer. Based on the in vitro and in vivo results, the in situ 3D printing technique followed by rapid cooling proved to be promising for bone tissue engineering. The absence of fibrous encapsulation and inflammatory processes became a good indicator of effectiveness in terms of biocompatibility parameters and bone tissue formation, and the use of the portable 3D printer showed a significant advantage in the application of this material by in situ printing.

Enhanced Photocatalytic Performance of TiO2@Er-Hydroxyapatite Composite for Cationic Dye and Drug Removal

Photocatalysis heterogeneous is an essential method for water treatment. In this study, a novel photocatalytic erbium-doped hydroxyapatite-decorated titanium dioxide (TiO2@Er-Hap) was obtained using the sol-gel method and applied to remove ciprofloxacin (CIP) drug and methylene blue (MB) dye contaminants. The sample's structural, physical, morphological, and photocatalytic properties were investigated. X-ray diffraction (XRD) confirmed the presence of the anatase phase in TiO2@Er-Hap. The oxide nanoparticles were deposited on the Hap surface, and the proposed material presented a band gap energy of 3.33 eV. Furthermore, TiO2@Er-Hap presented a larger surface area when compared with the material not decorated with the oxide. Photocatalysis tests performed under ultraviolet (UV) irradiation showed that TiO2@Er-Hap removed MB dye (100%) and CIP (71.16%), despite low mineralization evidenced in TOC analysis. The irradiated pollutant solution after the photocatalysis process was nontoxic, as observed in the ecotoxic test, indicating that the photocatalytic worked. Inhibitor tests showed that the •OH radicals were the main species involved in the tests performed. The material demonstrated activity even after five consecutive cycles of use. Finally, the results suggest that TiO2@Er-Hap is a suitable candidate for water decontamination via photocatalytic processes.

A Brief Photocatalytic Study of ZnO Containing Cerium towards Ibuprofen Degradation

Ibuprofen (IBU) is one of the most-sold anti-inflammatory drugs in the world, and its residues can reach aquatic systems, causing serious health and environmental problems. Strategies are used to improve the photocatalytic activity of zinc oxide (ZnO), and thosethat involvethe inclusion of metalhave received special attention. The aim of this work was to investigate the influence of the parameters and toxicity of a photoproduct using zinc oxide that contains cerium (ZnO-Ce) for the photodegradation of ibuprofen. The parameters include the influence of the photocatalyst concentration (0.5, 0.5, and 1.5 g L-1) as well as the effects of pH (3, 7, and 10), the effect of H2O2, and radical scavengers. The photocatalyst was characterized by Scanning Electron Microscopy-Energy Dispersive Spectroscopy, Transmission electron microscopy, Raman, X-Ray Diffraction, surface area, and diffuse reflectance. The photocatalytic activity of ibuprofen was evaluated in an aqueous solution under UV light for 120 min. The structural characterization by XRD and SEM elucidated the fact that the nanoparticle ZnO contained cerium. The band gap value was 3.31 eV. The best experimental conditions for the photodegradation of IBU were 60% obtained in an acidic condition using 0.50 g L-1 of ZnO-Ce in a solution of 20 ppm of IBU. The presence of hydrogen peroxide favored the photocatalysis process. ZnO-Ce exhibited good IBU degradation activity even after three photocatalytic cycles under UV light. The hole plays akey role in the degradation process of ibuprofen. The toxicity of photolyzed products was monitored against Artemia salina (bioindicator) and did not generate toxic metabolites. Therefore, this work provides a strategic design to improve ZnO-Ce photocatalysts for environmental remediation.

3D Printing in Development of Nanomedicines

Three-dimensional (3D) printing is gaining numerous advances in manufacturing approaches both at macro- and nanoscales. Three-dimensional printing is being explored for various biomedical applications and fabrication of nanomedicines using additive manufacturing techniques, and shows promising potential in fulfilling the need for patient-centric personalized treatment. Initial reports attributed this to availability of novel natural biomaterials and precisely engineered polymeric materials, which could be fabricated into exclusive 3D printed nanomaterials for various biomedical applications as nanomedicines. Nanomedicine is defined as the application of nanotechnology in designing nanomaterials for different medicinal applications, including diagnosis, treatment, monitoring, prevention, and control of diseases. Nanomedicine is also showing great impact in the design and development of precision medicine. In contrast to the "one-size-fits-all" criterion of the conventional medicine system, personalized or precision medicines consider the differences in various traits, including pharmacokinetics and genetics of different patients, which have shown improved results over conventional treatment. In the last few years, much literature has been published on the application of 3D printing for the fabrication of nanomedicine. This article deals with progress made in the development and design of tailor-made nanomedicine using 3D printing technology.